Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1400118 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $7.04Day −3.16%Mkt cap $216M1Y −24.1%Off 52W high −31.4%Vol (1Y) 87.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 758 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest31.8% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)−0.85% |
| Top-10 13F concentration62.2% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$43.5M |
| ROE−38.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+18.9% |
| 1Y−24.1% |
| 3Y−55.9% |
| Since incept. (ann.)−23.6% |
Total return through 2026-07-29 · series begins 2023-07-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)87.0% |
| Ann. volatility (3Y)149.8% |
| Sharpe (1Y)−0.03 |
| Sharpe (3Y)0.38 |
| Max drawdown (1Y)−55.5% |
| Max drawdown (3Y)−89.7% |
| Beta (3Y vs SPY)3.37 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $6M | 3.58% | new |
| Woodline Partners LP | 1.0M | $5M | 3.26% | +0.0% |
| MARSHALL WACE, LLP | 966,253 | $5M | 3.15% | +23.8% |
| BAKER BROS. ADVISORS LP | 952,996 | $5M | 3.11% | +0.0% |
| Affinity Asset Advisors, LLC | 868,020 | $5M | 2.83% | −24.4% |
| MILLENNIUM MANAGEMENT LLC | 862,303 | $5M | 2.81% | +46.9% |
| BlackRock, Inc. | 799,943 | $4M | 2.61% | −1.7% |
| HHLR ADVISORS, LTD. | 724,800 | $4M | 2.36% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.33 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.40 | — | — | — |
| 2025-06-30 | 2025-08-13 | −$0.32 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$0.56 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
